{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:15:10Z","timestamp":1792880110569,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["KUN 2004\/3126"],"award-info":[{"award-number":["KUN 2004\/3126"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Netherlands Organisation for Scientific Research","award":["917.76.363"],"award-info":[{"award-number":["917.76.363"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.molimm.2010.12.022","type":"journal-article","created":{"date-parts":[[2011,1,23]],"date-time":"2011-01-23T09:19:07Z","timestamp":1295774347000},"page":"810-817","source":"Crossref","is-referenced-by-count":22,"title":["Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses"],"prefix":"10.1016","volume":"48","author":[{"given":"I. Jolanda M.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurjen","family":"Tel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Benitez-Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruurd","family":"Torensma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl G.","family":"Figdor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.molimm.2010.12.022_bib0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-8518-6-4","article-title":"CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection","volume":"6","author":"Angel","year":"2008","journal-title":"J. Immune Based Ther. Vaccines"},{"issue":"4","key":"10.1016\/j.molimm.2010.12.022_bib0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.coi.2008.07.007","article-title":"Accessing the therapeutic potential of immunostimulatory nucleic acids","volume":"20","author":"Barchet","year":"2008","journal-title":"Curr. Opin. Immunol."},{"issue":"7","key":"10.1016\/j.molimm.2010.12.022_bib0015","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1084\/jem.20052364","article-title":"Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake","volume":"203","author":"Benitez-Ribas","year":"2006","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.molimm.2010.12.022_bib0020","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.4049\/jimmunol.181.8.5219","article-title":"Activation of human plasmacytoid dendritic cells by TLR9 impairs Fcgamma-mediated uptake of immune complexes and presentation by MHC class II","volume":"181","author":"Benitez-Ribas","year":"2008","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.molimm.2010.12.022_bib0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/138955706776073411","article-title":"Modifying toll-like receptor 9 signaling for therapeutic use","volume":"6","author":"Bhattacharjee","year":"2006","journal-title":"Mini Rev. Med. Chem."},{"issue":"12","key":"10.1016\/j.molimm.2010.12.022_bib0030","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1172\/JCI33483","article-title":"Chemical modification: the key to clinical application of RNA interference?","volume":"117","author":"Corey","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.molimm.2010.12.022_bib0035","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1128\/IAI.00580-09","article-title":"Mycobacterium tuberculosis culture filtrate proteins plus CpG oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion","volume":"77","author":"da Fonseca","year":"2009","journal-title":"Infect. Immun."},{"issue":"14","key":"10.1016\/j.molimm.2010.12.022_bib0040","first-page":"5091","article-title":"Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients","volume":"9","author":"de Vries","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.molimm.2010.12.022_bib0045","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/viro.2001.1232","article-title":"Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus","volume":"292","author":"Germi","year":"2002","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.molimm.2010.12.022_bib0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2008.06.017","article-title":"Plasmacytoid dendritic cells mediate oral tolerance","volume":"29","author":"Goubier","year":"2008","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.molimm.2010.12.022_bib0055","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20060401","article-title":"Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation","volume":"203","author":"Guiducci","year":"2006","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.molimm.2010.12.022_bib0060","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/eji.200323813","article-title":"Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells","volume":"33","author":"Hartmann","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.022_bib0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000086657","article-title":"TLR signalling and the function of dendritic cells","volume":"86","author":"Hemmi","year":"2005","journal-title":"Chem. Immunol. Allergy"},{"issue":"6813","key":"10.1016\/j.molimm.2010.12.022_bib0070","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2010.12.022_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/SQB.1989.054.01.003","article-title":"Approaching the asymptote? Evolution and revolution in immunology","volume":"54 Pt 1","author":"Janeway","year":"1989","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"issue":"6","key":"10.1016\/j.molimm.2010.12.022_bib0080","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ni0602-499","article-title":"Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848","volume":"3","author":"Jurk","year":"2002","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.molimm.2010.12.022_bib0085","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.molimm.2010.12.022_bib0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1615\/CritRevImmunol.v20.i5.30","article-title":"Critical roles of Toll-like receptors in host defense","volume":"20","author":"Kaisho","year":"2000","journal-title":"Crit. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.molimm.2010.12.022_bib0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/1566524033479726","article-title":"Regulation of dendritic cell function through Toll-like receptors","volume":"3","author":"Kaisho","year":"2003","journal-title":"Curr. Mol. Med."},{"issue":"5","key":"10.1016\/j.molimm.2010.12.022_bib0100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nm1589","article-title":"Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists","volume":"13","author":"Kanzler","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.molimm.2010.12.022_bib0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2005.04.010","article-title":"Cell type-specific involvement of RIG-I in antiviral response","volume":"23","author":"Kato","year":"2005","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.molimm.2010.12.022_bib0110","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.170.9.4465","article-title":"Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells","volume":"170","author":"Kerkmann","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.022_bib0115","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2010.12.022_bib0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1471-4906(01)02150-0","article-title":"From A to Z on CpG","volume":"23","author":"Krieg","year":"2002","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2010.12.022_bib0125","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1172\/JCI31414","article-title":"Development of TLR9 agonists for cancer therapy","volume":"117","author":"Krieg","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molimm.2010.12.022_bib0130","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-065X.2007.00572.x","article-title":"Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity","volume":"220","author":"Krieg","year":"2007","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.molimm.2010.12.022_bib0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ni1028","article-title":"TLR9 signals after translocating from the ER to CpG DNA in the lysosome","volume":"5","author":"Latz","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2010.12.022_bib0140","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2010.12.022_bib0145","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4049\/jimmunol.177.2.1028","article-title":"Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells","volume":"177","author":"Montoya","year":"2006","journal-title":"J. Immunol."},{"issue":"17","key":"10.1016\/j.molimm.2010.12.022_bib0150","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJMcibr070454","article-title":"Tolls and beyond\u2014many roads to vaccine immunity","volume":"356","author":"Pulendran","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.molimm.2010.12.022_bib0155","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2010.12.022_bib0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coi.2007.10.009","article-title":"Division of labor, plasticity, and crosstalk between dendritic cell subsets","volume":"20","author":"Pulendran","year":"2008","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2010.12.022_bib0165","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.molimm.2010.12.022_bib0170","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ni.1919","article-title":"Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel","volume":"11","author":"Schmidt","year":"2010","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.molimm.2010.12.022_bib0175","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1182\/blood-2009-11-251884","article-title":"Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells","volume":"116","author":"Schreibelt","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.molimm.2010.12.022_bib0180","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.4049\/jimmunol.174.4.2273","article-title":"CpG RNA: identification of novel single-stranded RNA that stimulates human CD14+CD11c+monocytes","volume":"174","author":"Sugiyama","year":"2005","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.molimm.2010.12.022_bib0185","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1615\/CritRevImmunol.v26.i6.50","article-title":"DNA motifs suppressing TLR9 responses","volume":"26","author":"Trieu","year":"2006","journal-title":"Crit. Rev. Immunol."},{"issue":"15","key":"10.1016\/j.molimm.2010.12.022_bib0190","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.vaccine.2008.01.043","article-title":"A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589011000149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589011000149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T02:35:57Z","timestamp":1559961357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589011000149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":38,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0161589011000149"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2010.12.022","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}